Discover Medicine

OCT 24, 2026 · JOURNAL ARTICLE

Antibiotic use among patients with malaria and co-existing diagnoses in tertiary hospitals in Uganda

Discover Medicine

Inappropriate antibiotic use is a major contributor to antimicrobial resistance (AMR) worldwide, especially in settings with high disease burden. This study used Point Prevalence S

SEP 18, 2026 · JOURNAL ARTICLE

Lean MAFLD and MASLD represent an underrecognized high risk phenotype beyond body mass index

Discover Medicine

Metabolic dysfunction-associated fatty liver disease (MAFLD) and the more recently proposed metabolic dysfunction-associated steatotic liver disease (MASLD) represent diagnostic fr

SEP 11, 2026 · JOURNAL ARTICLE

Current evidence on the diagnosis and management of immune checkpoint inhibitor associated myocarditis

Discover Medicine

A narrative review synthesizing observational evidence and consensus diagnostic/management criteria from cardio-oncology societies to inform structured multidisciplinary care of a rare life-threatening adverse event.

SEP 7, 2026 · REVIEW

A narrative review on immune checkpoint inhibitor drug interactions with statins, proton pump inhibitors and corticosteroids

Discover Medicine

A narrative review synthesizing observational and meta-analytic evidence on drug–ICI interactions, offering clinical recommendations on statin, PPI, and corticosteroid use during checkpoint inhibitor therapy, but not reporting new primary data.

AUG 10, 2026 · JOURNAL ARTICLE

Isocitrate dehydrogenase (IDH) as target for anticancer therapy in brain and gastrointestinal cancers

Discover Medicine

A narrative review synthesizing evidence on IDH inhibitors across multiple cancer types, discussing FDA-approved agents, clinical trial data, and resistance mechanisms—informative for clinical decision-making but not reporting original empirical results.